These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10920471)

  • 1. Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile.
    Grözinger M; Härtter S; Wang X; Röschke J; Hiemke C; Rose DM
    Arch Gen Psychiatry; 2000 Aug; 57(8):812-3. PubMed ID: 10920471
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.
    von Bahr C; Ursing C; Yasui N; Tybring G; Bertilsson L; Röjdmark S
    Eur J Clin Pharmacol; 2000 May; 56(2):123-7. PubMed ID: 10877005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans.
    Spigset O; Carleborg L; Hedenmalm K; Dahlqvist R
    Clin Pharmacol Ther; 1995 Oct; 58(4):399-403. PubMed ID: 7586931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and its receptors: a new class of sleep-promoting agents.
    Doghramji K
    J Clin Sleep Med; 2007 Aug; 3(5 Suppl):S17-23. PubMed ID: 17824497
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients.
    Carrillo JA; Ramos SI; Herraiz AG; Llerena A; Agundez JA; Berecz R; Duran M; Benítez J
    J Clin Psychopharmacol; 1999 Dec; 19(6):494-9. PubMed ID: 10587283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.
    Yoshida K; Higuchi H; Kamata M; Takahashi H; Inoue K; Suzuki T; Itoh K; Ozaki N
    J Psychopharmacol; 2007 Aug; 21(6):650-6. PubMed ID: 17092970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin secretion during fluvoxamine treatment in medicated chronic schizophrenic patients: evidence for the development of tolerance to selective serotonin re-uptake inhibitor.
    Silver H; Barash I; Odnopozov N; Jahjah N; Mizruhin A
    Biol Psychiatry; 1996 Jul; 40(1):75-7. PubMed ID: 8780859
    [No Abstract]   [Full Text] [Related]  

  • 8. Melatonin for the treatment of disorders in circadian rhythm and sleep: could it form a basis for medication?
    Nir I
    Recept Channels; 2003; 9(6):379-85. PubMed ID: 14698965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent effect of the CYP2D6 genotype on the steady-state fluvoxamine concentration.
    Watanabe J; Suzuki Y; Fukui N; Sugai T; Ono S; Inoue Y; Someya T
    Ther Drug Monit; 2008 Dec; 30(6):705-8. PubMed ID: 18978520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichotilliomania responding to low-dose fluvoxamine.
    Ikenouchi-Sugita A; Yoshimura R; Ueda N; Nakamura J
    Psychiatry Clin Neurosci; 2009 Oct; 63(5):701-2. PubMed ID: 19788633
    [No Abstract]   [Full Text] [Related]  

  • 11. A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction.
    Sunami E; Usuda K; Nishiyama Y; Otori T; Katsura K; Katayama Y
    Intern Med; 2012; 51(10):1187-93. PubMed ID: 22687788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.
    Eap CB; Bertschy G; Powell K; Baumann P
    J Clin Psychopharmacol; 1997 Apr; 17(2):113-7. PubMed ID: 10950475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-release fluvoxamine (Luvox CR).
    Med Lett Drugs Ther; 2008 Jun; 50(1289):50-1. PubMed ID: 18583947
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated alleles.
    Suzuki Y; Shioiri T; Muratake T; Kawashima Y; Sato S; Hagiwara M; Inoue Y; Shimoda K; Someya T
    Eur J Clin Pharmacol; 2003 Apr; 58(12):829-33. PubMed ID: 12698310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Musing about melatonin and sleep: it's all about timing.
    Turek FW
    Sleep; 2006 May; 29(5):606-7. PubMed ID: 16774149
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of melatonin in the regulation of human circadian rhythms and sleep.
    Cajochen C; Kräuchi K; Wirz-Justice A
    J Neuroendocrinol; 2003 Apr; 15(4):432-7. PubMed ID: 12622846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin--to sleep, perchance to dream.
    Powers JE; Kees M
    S D J Med; 1996 May; 49(5):164-5. PubMed ID: 8936019
    [No Abstract]   [Full Text] [Related]  

  • 18. Melatonin potentially useful but safety, efficacy remain uncertain.
    Lamberg L
    JAMA; 1996 Oct; 276(13):1011-4. PubMed ID: 8847748
    [No Abstract]   [Full Text] [Related]  

  • 19. [Melatonin receptor agonist].
    Uchiyama M
    Nihon Rinsho; 2015 Jun; 73(6):1017-22. PubMed ID: 26065135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype-phenotype association study design in translational pharmacogenetics.
    Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Inoue Y; Ozdemir V; Someya T
    J Psychopharmacol; 2011 Jul; 25(7):908-14. PubMed ID: 20547595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.